Establishment Labs Overview
- Founded
-
2004

- Status
-
Public
- Employees
-
887

- Stock Symbol
-
ESTA

- Investments
-
3
- Share Price
-
$67.22
- (As of Monday Closing)
Establishment Labs General Information
Description
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in designing, manufacturing, and marketing silicone-filled breast and body shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
Contact Information
- Coyol Free Zone
- Alajuela
- Costa Rica
Establishment Labs Stock Performance
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$67.22 | $66.02 | $44.02 - $93.80 | $1.64B | 24.3M | 161K | -$3.12 |
Establishment Labs Financials Summary
In Thousands, USD |
TTM 30-Sep-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
---|---|---|---|---|
EV | 1,381,648 | 1,611,530 | 850,208 | 575,378 |
Revenue | 153,200 | 126,682 | 84,676 | 89,565 |
EBITDA | (57,449) | (26,549) | (24,948) | (25,530) |
Net Income | (75,838) | (41,139) | (38,121) | (38,150) |
Total Assets | 187,653 | 139,529 | 156,388 | 116,531 |
Total Debt | 152,074 | 54,208 | 52,543 | 48,400 |
Establishment Labs Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Establishment Labs Comparisons
Industry
Financing
Details
Establishment Labs Competitors (9)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Integra Lifesciences Holdings | Corporation | Princeton, NJ | 0000 | 00000 | 000000 - 000 | 00000 |
000000 | Formerly VC-backed | Irvine, CA | 000 | 0000 | 00000000 | 0000 |
00000 0000000 | Formerly VC-backed | Toronto, Canada | 000 | 00000 | 000000000 | 00000 |
0000000 | Formerly VC-backed | Santa Barbara, CA | 000 | 00000 | 000000 - 000 | 00000 |
000000000 | Corporation | Minneapolis, MN | 00000 | 00000000 |
Establishment Labs Patents
Establishment Labs Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20220338808-A1 | Methods and systems for sensing parameters in implantable devices | Pending | 02-Oct-2019 | 00000000 | |
CA-3156319-A1 | Methods and systems for sensing parameters in implantable devices | Pending | 02-Oct-2019 | 000000000 | |
EP-4041059-A1 | Methods and systems for sensing parameters in implantable devices | Pending | 02-Oct-2019 | 000000000 | |
EP-3860479-A1 | Insertion devices and methods of use thereof | Pending | 03-Oct-2018 | 000000000 | |
US-20200111213-A1 | Systems and methods of monitoring medical implants | Pending | 03-Oct-2018 | G06T7/0014 | 0 |
Establishment Labs Executive Team (11)
Establishment Labs Board Members (11)
Name | Representing | Role | Since |
---|---|---|---|
Dennis Condon | Establishment Labs | Board Member | 000 0000 |
Edward Schutter | Establishment Labs | Board Member | 000 0000 |
Juan Chacón-Quirós | Establishment Labs | Founder, Chief Executive Officer & Board Member | 000 0000 |
Leslie Gillin | Self | Board Member | 000 0000 |
Lisa Colleran | Establishment Labs | Board Member | 000 0000 |
Establishment Labs Signals
Establishment Labs Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Establishment Labs Investments & Acquisitions (3)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000 0000000 ( | 31-Jan-2019 | 000000000 | 00.000 | Buildings and Property | |
00000000 (000 | 17-Nov-2017 | 0000000000 | 00.000 | Distributors/Wholesale | |
Magna Equities I (Certain Assets) | 01-Nov-2015 | Corporate Asset Purchase | Buildings and Property |
Establishment Labs ESG
Risk Overview
Risk Rating
Updated April, 01, 2022
38.51 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.00
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,613
Rank
Percentile

Healthcare
Industry
00 of 635
Rank
Percentile

Medical Devices
Subindustry
00 of 228
Rank
Percentile
